Viewing Study NCT01359618


Ignite Creation Date: 2025-12-25 @ 4:33 AM
Ignite Modification Date: 2026-02-07 @ 7:14 PM
Study NCT ID: NCT01359618
Status: TERMINATED
Last Update Posted: 2012-12-12
First Post: 2011-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Heart
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Male View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase I View
None Safety View
None tolerability View
None healthy View
None major depressive disorder View
None thorough QT View
None maximum tolerated dose View
None elimination View
None heart electrical signal View